BioSpace News Archive

Genetown

New Peer Reviewed Publication Shows That BrainStorm’s NurOwn Has a Unique miRNA Signature

The publication shows that NurOwn - mesenchymal stem cells induced to secrete neurotrophic factors - have both an enhanced secretion of NTFs as well as a distinct miRNA expression profile that distinguishes them from their MSCs of origin.

November 9, 2017

·

4 min read

Business

PhaseRx Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Total operating expenses for the third quarter of 2017 were $2.5 million, compared to $3.1 million of operating expenses in the third quarter of 2016.

November 9, 2017

·

11 min read

Drug Development

OncoSec Announces Preclinical Data Demonstrating Multi-Gene Expression Platform for Delivery of Multiple Cancer Immunotherapies at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2017

The PIIM platform builds upon OncoSec’s existing plasmid-based cancer immunotherapy platform and may offer both enhanced therapeutic activity as well as manufacturing efficiencies.

November 9, 2017

·

6 min read

Business

Therapix Biosciences Reports Third Quarter 2017 Financial Results and Provides Business Update

The Company will host a conference call and webcast today to discuss the financial results and to provide an update on current developments with respect to its clinical programs.

November 9, 2017

·

39 min read

Business

Eiger BioPharmaceuticals Reports Third Quarter 2017 Financial Results

Net loss for the third quarter of 2017 was $9.2 million, or $1.10 per share basic and diluted, compared to a net loss of $11.4 million, or $1.49 per share basic and diluted for the third quarter of 2016. Net losses were $31.6 million and $34.3 million for the nine months ended September30, 2017 and 2016.

November 9, 2017

·

11 min read

Drug Development

Novaliq Announces First Patient Randomized in Its ESSENCE Phase 2b/3 Trial of CyclASol for the Treatment of the Signs and Symptoms of Dry Eye Disease

CyclASol potentially overcomes the current intolerability and efficacy profiles due to the benefits of a water-free vehicle and the mechanism of drug delivery.

November 9, 2017

·

3 min read

Business

Wave Life Sciences Reports Third Quarter 2017 Financial Results and Provides Business Update

Wave reported a net loss of $26.1 million for the third quarter of 2017, as compared to a net loss of $17.5 million for the third quarter of 2016.

November 9, 2017

·

10 min read

Business

Pivot Pharma Licenses Thrudermic Transdermal Nanotechnology and Expands Scientific Advisory Board

Pivot Pharma is pleased to announce the signing of a Binding Letter of Intent with Thrudermic, LLC, a privately held North Carolina company, to acquire worldwide rights to Thrudermic’s Transdermal Nanotechnology for the development and commercialization of topical cannabinoids.

November 9, 2017

·

4 min read

Biotech Beach

LIGHTMED Corporation Awarded Tender for Ophthalmic Laser Equipment From Mexico’s Ministry of Health

The Mexican government chose the LIGHTLas 810 laser for its bells and whistles.

November 9, 2017

·

2 min read

Pharm Country

Medidata Introduces New Strategic Monitoring Suite to Ensure Sponsors and Sites Meet ICH E6 Guidelines

Medidata announced the launch of its Strategic Monitoring suite, which meets ICH E6 guidelines and exceeds requirements by empowering clinical research teams to collaborate and manage all cross-functional, risk management and centralized data monitoring activities through seamless, end-to-end workflows.

November 9, 2017

·

4 min read